ProMIS Neurosciences Inc.
PMN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374339
In the last 90 days, ProMIS Neurosciences Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $84.3M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding ProMIS Neurosciences Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 17 | 19 | +2 |
| Shares | 9.31M | 8.47M | −841.6K (−9.0%) |
| Value | $6.49M | $4.10M | −$2.39M (−36.8%) |
New holders (5)
Institutions that held ProMIS Neurosciences Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 63,429 | $31.1K | 0.00% |
| Graypoint LLC | 52,833 | $25.6K | 0.00% |
| Kingsview Wealth Management, LLC | 31,062 | $15.0K | 0.00% |
| Howard Financial Services, Ltd. | 26,042 | $12.6K | 0.00% |
| Commonwealth Equity Services, LLC | 11,447 | $6.00K | 0.00% |
Sold out (3)
Institutions that held ProMIS Neurosciences Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Altium Capital Management LP | 574,248 | $399.4K |
| Heights Capital Management, Inc | 18,267 | $12.9K |
| Abound Wealth Management | 1 | $1 |